Cedar Mountain Advisors
VRTX icon

Cedar Mountain Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Cedar Mountain Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$30.8K Buy
59
+5
+9% +$2.56K 0.01% 230
2026
Q2 		$26.8K Hold
54
– – ﹤0.01% 277
2026
Q1 		$24.1K Buy
54
+16
+42% +$7.46K ﹤0.01% 257
2025
Q4 		$17.2K Hold
38
– – ﹤0.01% 199
2025
Q3 		$14.9K Buy
38
+3
+9% +$1.25K ﹤0.01% 215
2025
Q2 		$15.6K Hold
35
– – ﹤0.01% 184
2025
Q1 		$17K Sell
35
-2
-5% -$932 ﹤0.01% 167
2024
Q4 		$14.9K Sell
37
-7
-16% -$3.24K ﹤0.01% 178
2024
Q3 		$20.5K Hold
44
– – ﹤0.01% 149
2024
Q2 		$20.6K Hold
44
– – 0.01% 136
2024
Q1 		$18.4K Hold
44
– – ﹤0.01% 142
2023
Q4 		$17.9K Hold
44
– – ﹤0.01% 140
2023
Q3 		$15.3K Buy
+44
New +$15.4K ﹤0.01% 137

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Cedar Mountain Advisors's VRTX Position: Q3 2026 in Review

Cedar Mountain Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 9.3% in Q3 2026, buying an estimated $2.56K and bringing the position to 59 shares worth $30.8K. The position accounts for 0.01% of the portfolio, ranked #230.

Cedar Mountain Advisors first reported a position in VRTX in Q3 2023 and has held it in 13 quarters since. 346 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Cedar Mountain Advisors held 59 shares of Vertex Pharmaceuticals worth $30.8K as of Q3 2026.
  • Cedar Mountain Advisors bought 5 Vertex Pharmaceuticals shares in Q3 2026, an estimated $2.56K.
  • Vertex Pharmaceuticals made up 0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #230 holding.
  • Cedar Mountain Advisors first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 13 quarters since.
  • 346 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.